Multiple immune signaling proteins and pathways

Multiple immune signaling proteins and pathways represent a broad classification of various molecular cascades that coordinate the immune system's response to internal and external stimuli (Nature Reviews Immunology, 2021). This category includes essential pathways such as the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, and the Toll-like receptor (TLR) signaling network (PubMed, PMC4058071). These systems are fundamental for cell-to-cell communication, cytokine production, and the activation of innate and adaptive immunity. Dysregulation of these pathways is frequently implicated in the pathogenesis of autoimmune diseases, chronic inflammatory conditions, and malignancies (StatPearls, 2023). Because this term describes a collection of diverse proteins and interactions rather than a single specific receptor or enzyme, it is not considered a valid individual therapeutic target. Drug discovery efforts typically focus on specific components within these pathways, such as individual kinases or receptors, to modulate immune activity with higher precision and fewer side effects (Frontiers in Immunology, 2020).

Other names

Immune signaling pathwaysInflammatory signaling cascadesCytokine signaling pathwaysImmune system signaling

Not applicable as this refers to a broad category of biological processes and multiple distinct molecular targets rather than a single entity. Drugs interacting with components of these pathways typically act via kinase inhibition, receptor antagonism, or neutralization of signaling ligands.